Source:http://linkedlifedata.com/resource/pubmed/id/19204325
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2009-5-8
|
pubmed:abstractText |
We recently isolated a novel angiogenesis inhibitor, vasohibin-1, and its homologue, vasohibin-2. In this study we characterize the role of these 2 molecules in the regulation of angiogenesis. In a mouse model of subcutaneous angiogenesis, the expression of endogenous vasohibin-1 was low in proliferating ECs at the sprouting front but high in nonproliferating endothelial cells (ECs) in the termination zone. In contrast, endogenous vasohibin-2 was preferentially expressed in mononuclear cells mobilized from bone marrow that infiltrated the sprouting front. When applied exogenously, vasohibin-1 inhibited angiogenesis at the sprouting front where endogenous vasohibin-1 was scarce but did not influence vascularity in the termination zone where endogenous vasohibin-1 was enriched. Exogenous vasohibin-2 prevented the termination of angiogenesis in the termination zone and increased vascularity in this region. Angiogenesis was persistent in the termination zone in the vasohibin-1 knockout mice, whereas angiogenesis was deficient at the sprouting front in the vasohibin-2 knockout mice. Supplementation of deficient proteins normalized the abnormal patterns of angiogenesis in the vasohibin knockout mice. These results indicate that vasohibin-1 is expressed in ECs in the termination zone to halt angiogenesis, whereas vasohibin-2 is expressed in infiltrating mononuclear cells in the sprouting front to promote angiogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1528-0020
|
pubmed:author |
pubmed-author:FujiwaraTakashiT,
pubmed-author:KimuraHiroshiH,
pubmed-author:KobayashiMihoM,
pubmed-author:MiyashitaHirokiH,
pubmed-author:OhtaHidekiH,
pubmed-author:SatoYasufumiY,
pubmed-author:ShimosegawaTooruT,
pubmed-author:SonodaHikaruH,
pubmed-author:SuzukiYasuhiroY,
pubmed-author:WatanabeKazuhideK
|
pubmed:issnType |
Electronic
|
pubmed:day |
7
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4810-8
|
pubmed:meshHeading |
pubmed-meshheading:19204325-Adenoviridae,
pubmed-meshheading:19204325-Animals,
pubmed-meshheading:19204325-Blotting, Northern,
pubmed-meshheading:19204325-Cell Cycle Proteins,
pubmed-meshheading:19204325-Endothelial Cells,
pubmed-meshheading:19204325-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19204325-Female,
pubmed-meshheading:19204325-Immunoenzyme Techniques,
pubmed-meshheading:19204325-Male,
pubmed-meshheading:19204325-Mice,
pubmed-meshheading:19204325-Mice, Inbred C57BL,
pubmed-meshheading:19204325-Mice, Knockout,
pubmed-meshheading:19204325-Neovascularization, Pathologic,
pubmed-meshheading:19204325-Neovascularization, Physiologic,
pubmed-meshheading:19204325-RNA, Messenger,
pubmed-meshheading:19204325-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19204325-Skin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.
|
pubmed:affiliation |
Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|